Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acoladi soft capsule in advanced hepatocellular carcinoma
CTR20150122Phase 2Completed
- Sponsor
- Shenogen Pharma Group
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Icaritin in hepatocellular carcinoma (HCC), sponsored by Shenogen Pharma Group. Started Jun 2015; status: completed.
02
Drugs
Icaritin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on CTR20150122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150122.